In a similar fashion, in a study by Khalifa et al., 42 lymphoma patients were evaluated for the presence of M-MDSCs (CD14+HLA-DRlow/–) in peripheral blood, with 26 newly diagnosed and 16 relapsed/refractory [62]. Here, CD14 is linked to lymphoma.